|
1）Oliver G, Schäfer EA. On the Physiological Action of Extracts of Pituitary Body and certain other Glandular Organs: Preliminary Communication. J Physiol. 1895; 18: 277-9
|
|
|
|
2）Turner RA, Pierce JG, Du Vigneaud V. The purification and the amino acid content of vasopressin preparations. J Biol Chem. 1951; 191: 21-8
|
|
|
|
|
3）du Vigneaud V, Gish DT, Katsoyannis PG. A synthetic preparation possessing biological properties associated with arginine-vasopressin. J Am Chem Soc. 1954; 76: 4751-2
|
|
|
|
|
|
4）Caldwell HK, Lee HJ, Macbeth AH, et al. Vasopressin: behavioral roles of an “original” neuropeptide. Prog Neurobiol. 2008; 84: 1-24
|
|
|
|
|
|
5）Insel TR. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron. 2010; 65: 768-79
|
|
|
|
|
|
6）Yamaguchi Y, Suzuki T, Mizoro Y, et al. Mice genetically deficient in vasopressin V1a and V1b receptors are resistant to jet lag. Science. 2013; 342: 85-90
|
|
|
|
|
|
7）Buxton OM, Cain SW, OʼConnor SP, et al. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med. 2012; 4: 129ra43
|
|
|
|
|
|
8）Scheer FA, Hilton MF, Mantzoros CS, et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A. 2009; 106: 4453-8
|
|
|
|
|
|
9）Moser M, et al. Cancer and rhythm. Cancer Causes Control. 2006; 17: 483-7
|
|
|
|
|
|
10）Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science. 2005; 308: 1043-5
|
|
|
|
|
|
11）Doi M, Takahashi Y, Komatsu R, et al. Salt-sensitive hypertension in circadian clock-deficient mice involves dysregulated adrenal Hsd3b6. Nat Med. 2010; 16: 67-74
|
|
|
|
|
|
12）Hastings MH, Maywood ES, OʼNeil JS. Cellular circadian pacemaking and the role of cytosolic rhythms. Curr Biol. 2008; 18: R805-15
|
|
|
|
|
|
13）Okamura H. Clock genes and cell clocks: Roles, actions and mysteries. J Biol Rhythms. 2004; 19: 388-99
|
|
|
|
|
|
14）Okamura H. Suprachiasmatic nucleus clock time in the mammalian circadian system. Cold Spring Harb Symp Quant Biol. 2007; 72: 551-6
|
|
|
|
|
|
15）Ibata Y, Tanaka M, Tamada Y, et al. The suprachiasmatic nucleus: A circadian oscillator. Neuroscientist. 1997; 3: 215-25
|
|
|
|
|
|
16）Vandesande F, Dierickx K, DeMey J. Identification of the vasopressin-neurophysin producing neurons of the rat suprachiasmatic nuclei. Cell Tissue Res. 1975; 156: 377-80
|
|
|
|
|
|
17）Swaab DF, Pool CW, Nijveldt F. Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophypopseal system. J Neural Transm. 1975; 36: 195-215
|
|
|
|
|
|
18）Schwartz WJ, Reppert SM. Neural regulation of the circadian vasopressin rhythm in cerebrospinal fluid: a pre-eminent role for the suprachiasmatic nuclei. J Neurosci. 1985; 5: 2771-8
|
|
|
|
|
|
19）Jin X, Shearman LP, Weaver DR, et al. A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell. 1999; 96: 57-68
|
|
|
|
|
|
20）Tominaga K, Inouye SI, Okamura H. Organotypic slice culture of the rat suprachiasmatic nucleus: sustenance of cellular architecture and circadian rhythm. Neuroscience. 1994; 59: 1025-42
|
|
|
|
|
|
21）Young WS III, Kovács K, Lolait SJ. The diurnal rhythm in vasopressin V1a receptor expression in the suprachiasmatic nucleus is not dependent on vasopressin. Endocrinology. 1993; 133: 585-90
|
|
|
|
|
|
22）Lim M, Wang Z, Olazábal DE, et al. Enhanced partner preference in a promiscuous species by manipulating the expression of a single gene. Nature. 2004; 429: 754-7
|
|
|
|
|
|
23）Masuki S, Sumiyoshi E, Koshimizu TA, et al. Voluntary locomotion linked with cerebral activation is mediated by vasopressin V1a receptors in free-moving mice. J Physiol. 2013; 591: 3651-65
|
|
|
|
|
|
24）Castel M, Feinstein N, Cohen S, et al. Vasopressinergic innervation of the mouse suprachiasmatic nucleus: an immunoelectron microscopic analysis. J Comp Neurol. 1990; 298: 172-87
|
|
|
|
|
|
25）Yamaguchi S, Isejima H, Matsuo T, et al. Synchronization of cellular clocks in the suprachiasmatic nucleus. Science. 2003; 302: 1408-12
|
|
|
|
|
|
26）Peri A. Clinical review: the use of vaptans in clinical endocrinology. J Clin Endocrinol Metab. 2013; 98: 1321-32
|
|
|
|
|
|
27）Kalsbeek A, Fliers E, Hofman MA, et al. Vasopressin and the output of the hypothalamic biological clock. J Neuroendocrinol. 2010; 22: 362-72
|
|
|
|
|
|
28）Hoorneman EMD, Buijs RM. Vasopressin fiber pathways in the rat brain following suprachiasmatic nucleus lesioning. Brain Res. 1982; 243: 235-41
|
|
|
|
|